The COVID-19 pandemic has highlighted the urgency for regional health security, spurring an unprecedented drive since 2020 to establish a robust vaccine production capability within Africa.

Research based on cherry-picking statistics and small studies suited the needs of the pharmaceutical industry, but it may have been all wrong.

THE BAD NEWS? ALL THREE of the COVID-19 vaccines approved in the United States seem to be significantly less protective against the new Omicron variant...

Change Will Need To Be Forced by Patients And Their Doctors.